APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Colloids (Blood Plasma)

Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.

Colloids (Blood Plasma) can be applied for extensive burns, massive blood or plasma loss and hypovolemic shock. In this report, we calculate colloids (blood plasma) preparations, which is produced by albumin, gelatin, dextran and hydroxyethyl starch.

Selected research

Market Structure

Global Colloids (Blood Plasma) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 17397964038 January 2026197 pages

Choose your research edition.

Industry ResearchColloids (Blood Plasma) Industry Research Report 2026145 pages · $2,950 USDIndustry Growth & TrendsGlobal Colloids (Blood Plasma) Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Colloids (Blood Plasma) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Colloids (Blood Plasma) Market Outlook and Growth Opportunities 2026218 pages · $4,250 USDMarket Analysis & ForecastGlobal Colloids (Blood Plasma) Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.

Colloids (Blood Plasma) can be applied for extensive burns, massive blood or plasma loss and hypovolemic shock. In this report, we calculate colloids (blood plasma) preparations, which is produced by albumin, gelatin, dextran and hydroxyethyl starch.

North America is the largest Colloids (Blood Plasma) market with about 33% market share. Europe is follower, accounting for about 28% market share.

Read the full market overview

The key players are CSL Behring, Baxter, Grifols, Octapharma, Kedrion, Shanghai Raas, CTBB, Hualan Bio, Rongsheng Pharmaceutical, Boya Rongsheng, B. Braun Medical, Fresenius Kabi, HOSPIRA, Axa parenterals, Fresenius Kabi(China), CR Double-Crane, Kelun Group, Shandong Qidu Pharmaceutical, Shandong Hualu Pharmaceutical, Minsheng Pharma, Kanglepharm etc. Top 3 companies occupied about 46% market share.

This report provides an overview of the global Colloids (Blood Plasma) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Colloids (Blood Plasma) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Colloids (Blood Plasma) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Colloids (Blood Plasma) market size, projected growth trends, production technologies, key applications, and end-use industries.

Colloids (Blood Plasma) Segment by Company

CSL Behring

Baxter

Grifols

Octapharma

Kedrion

Shanghai Raas

CTBB

Hualan Bio

Rongsheng Pharmaceutical

Boya Rongsheng

B. Braun Medical

Fresenius Kabi

HOSPIRA

Axa parenterals

Fresenius Kabi (China)

CR Double-Crane

Kelun Group

Shandong Qidu Pharmaceutical

Shandong Hualu Pharmaceutical

Minsheng Pharma

Kanglepharm

Colloids (Blood Plasma) Segment by Type

Natural Type Colloids (Blood Plasma)

Synthetic Type Colloids (Blood Plasma)

Colloids (Blood Plasma) Segment by Application

Extensive Burns

Massive Blood or Plasma Loss

Hypovolemic Shock

Others

Colloids (Blood Plasma) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Colloids (Blood Plasma) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Colloids (Blood Plasma) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Colloids (Blood Plasma).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Colloids (Blood Plasma) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Colloids (Blood Plasma) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Colloids (Blood Plasma) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Colloids (Blood Plasma) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Colloids (Blood Plasma) Industry Trends Table 2. Colloids (Blood Plasma) Industry Drivers Table 3. Colloids (Blood Plasma) Industry Opportunities and Challenges Table 4. Colloids (Blood Plasma) Industry Restraints Table 5. Global Colloids (Blood Plasma) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Colloids (Blood Plasma) Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Colloids (Blood Plasma) Sales by Manufacturers (MT) & (2021-2026) Table 8. Global Colloids (Blood Plasma) Sales Market Share by Manufacturers Table 9. Global Colloids (Blood Plasma) Average Sales Price (USD/Kg) of Manufacturers (2021-2026) Table 10. Global Colloids (Blood Plasma) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Colloids (Blood Plasma) Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Colloids (Blood Plasma) Manufacturers, Product Type & Application Table 13. Global Colloids (Blood Plasma) Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Colloids (Blood Plasma) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Natural Type Colloids (Blood Plasma) Table 17. Major Manufacturers of Synthetic Type Colloids (Blood Plasma) Table 18. Global Colloids (Blood Plasma) Sales by Type 2021 VS 2025 VS 2032 (MT) Table 19. Global Colloids (Blood Plasma) Sales by Type (2021-2026) & (MT) Table 20. Global Colloids (Blood Plasma) Sales by Type (2027-2032) & (MT) Table 21. Global Colloids (Blood Plasma) Sales Market Share by Type (2021-2026) Table 22. Global Colloids (Blood Plasma) Sales Market Share by Type (2027-2032) Table 23. Global Colloids (Blood Plasma) Revenue by Type 2021 VS 2025 VS 2032 (MT) Table 24. Global Colloids (Blood Plasma) Revenue by Type (2021-2026) & (MT) Table 25. Global Colloids (Blood Plasma) Revenue by Type (2027-2032) & (MT) Table 26. Global Colloids (Blood Plasma) Revenue Market Share by Type (2021-2026) Table 27. Global Colloids (Blood Plasma) Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Extensive Burns Table 29. Major Manufacturers of Massive Blood or Plasma Loss Table 30. Major Manufacturers of Hypovolemic Shock Table 31. Major Manufacturers of Others Table 32. Global Colloids (Blood Plasma) Sales by Application 2021 VS 2025 VS 2032 (MT) Table 33. Global Colloids (Blood Plasma) Sales by Application (2021-2026) & (MT) Table 34. Global Colloids (Blood Plasma) Sales by Application (2027-2032) & (MT) Table 35. Global Colloids (Blood Plasma) Sales Market Share by Application (2021-2026) Table 36. Global Colloids (Blood Plasma) Sales Market Share by Application (2027-2032) Table 37. Global Colloids (Blood Plasma) Revenue by Application 2021 VS 2025 VS 2032 (MT) Table 38. Global Colloids (Blood Plasma) Revenue by Application (2021-2026) & (MT) Table 39. Global Colloids (Blood Plasma) Revenue by Application (2027-2032) & (MT) Table 40. Global Colloids (Blood Plasma) Revenue Market Share by Application (2021-2026) Table 41. Global Colloids (Blood Plasma) Revenue Market Share by Application (2027-2032) Table 42. Global Colloids (Blood Plasma) Sales by Region: 2021 VS 2025 VS 2032 (MT) Table 43. Global Colloids (Blood Plasma) Sales by Region (2021-2026) & (MT) Table 44. Global Colloids (Blood Plasma) Sales Market Share by Region (2021-2026) Table 45. Global Colloids (Blood Plasma) Sales Forecasted by Region (2027-2032) & (MT) Table 46. Global Colloids (Blood Plasma) Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Colloids (Blood Plasma) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (MT) Table 48. North America Colloids (Blood Plasma) Sales by Country (2021-2026) & (MT) Table 49. North America Colloids (Blood Plasma) Sales by Country (2027-2032) & (MT) Table 50. Europe Colloids (Blood Plasma) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (MT) Table 51. Europe Colloids (Blood Plasma) Sales by Country (2021-2026) & (MT) Table 52. Europe Colloids (Blood Plasma) Sales by Country (2027-2032) & (MT) Table 53. Asia Pacific Colloids (Blood Plasma) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (MT) Table 54. Asia Pacific Colloids (Blood Plasma) Sales by Country (2021-2026) & (MT) Table 55. Asia Pacific Colloids (Blood Plasma) Sales by Country (2027-2032) & (MT) Table 56. South America, Middle East and Africa Colloids (Blood Plasma) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (MT) Table 57. South America, Middle East and Africa Colloids (Blood Plasma) Sales by Country (2021-2026) & (MT) Table 58. South America, Middle East and Africa Colloids (Blood Plasma) Sales by Country (2027-2032) & (MT) Table 59. Global Colloids (Blood Plasma) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Colloids (Blood Plasma) Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Colloids (Blood Plasma) Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Colloids (Blood Plasma) Revenue Market Share by Region (2021-2026) Table 63. Global Colloids (Blood Plasma) Revenue Market Share by Region (2027-2032) Table 64. CSL Behring Company Information Table 65. CSL Behring Business Overview Table 66. CSL Behring Colloids (Blood Plasma) Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. CSL Behring Colloids (Blood Plasma) Product Portfolio Table 68. CSL Behring Recent Development Table 69. Baxter Company Information Table 70. Baxter Business Overview Table 71. Baxter Colloids (Blood Plasma) Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Baxter Colloids (Blood Plasma) Product Portfolio Table 73. Baxter Recent Development Table 74. Grifols Company Information Table 75. Grifols Business Overview Table 76. Grifols Colloids (Blood Plasma) Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Grifols Colloids (Blood Plasma) Product Portfolio Table 78. Grifols Recent Development Table 79. Octapharma Company Information Table 80. Octapharma Business Overview Table 81. Octapharma Colloids (Blood Plasma) Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Octapharma Colloids (Blood Plasma) Product Portfolio Table 83. Octapharma Recent Development Table 84. Kedrion Company Information Table 85. Kedrion Business Overview Table 86. Kedrion Colloids (Blood Plasma) Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Kedrion Colloids (Blood Plasma) Product Portfolio Table 88. Kedrion Recent Development Table 89. Shanghai Raas Company Information Table 90. Shanghai Raas Business Overview Table 91. Shanghai Raas Colloids (Blood Plasma) Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Shanghai Raas Colloids (Blood Plasma) Product Portfolio Table 93. Shanghai Raas Recent Development Table 94. CTBB Company Information Table 95. CTBB Business Overview Table 96. CTBB Colloids (Blood Plasma) Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. CTBB Colloids (Blood Plasma) Product Portfolio Table 98. CTBB Recent Development Table 99. Hualan Bio Company Information Table 100. Hualan Bio Business Overview Table 101. Hualan Bio Colloids (Blood Plasma) Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Hualan Bio Colloids (Blood Plasma) Product Portfolio Table 103. Hualan Bio Recent Development Table 104. Rongsheng Pharmaceutical Company Information Table 105. Rongsheng Pharmaceutical Business Overview Table 106. Rongsheng Pharmaceutical Colloids (Blood Plasma) Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Rongsheng Pharmaceutical Colloids (Blood Plasma) Product Portfolio Table 108. Rongsheng Pharmaceutical Recent Development Table 109. Boya Rongsheng Company Information Table 110. Boya Rongsheng Business Overview Table 111. Boya Rongsheng Colloids (Blood Plasma) Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Boya Rongsheng Colloids (Blood Plasma) Product Portfolio Table 113. Boya Rongsheng Recent Development Table 114. B. Braun Medical Company Information Table 115. B. Braun Medical Business Overview Table 116. B. Braun Medical Colloids (Blood Plasma) Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. B. Braun Medical Colloids (Blood Plasma) Product Portfolio Table 118. B. Braun Medical Recent Development Table 119. Fresenius Kabi Company Information Table 120. Fresenius Kabi Business Overview Table 121. Fresenius Kabi Colloids (Blood Plasma) Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Fresenius Kabi Colloids (Blood Plasma) Product Portfolio Table 123. Fresenius Kabi Recent Development Table 124. HOSPIRA Company Information Table 125. HOSPIRA Business Overview Table 126. HOSPIRA Colloids (Blood Plasma) Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. HOSPIRA Colloids (Blood Plasma) Product Portfolio Table 128. HOSPIRA Recent Development Table 129. Axa parenterals Company Information Table 130. Axa parenterals Business Overview Table 131. Axa parenterals Colloids (Blood Plasma) Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Axa parenterals Colloids (Blood Plasma) Product Portfolio Table 133. Axa parenterals Recent Development Table 134. Fresenius Kabi (China) Company Information Table 135. Fresenius Kabi (China) Business Overview Table 136. Fresenius Kabi (China) Colloids (Blood Plasma) Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. Fresenius Kabi (China) Colloids (Blood Plasma) Product Portfolio Table 138. Fresenius Kabi (China) Recent Development Table 139. CR Double-Crane Company Information Table 140. CR Double-Crane Business Overview Table 141. CR Double-Crane Colloids (Blood Plasma) Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 142. CR Double-Crane Colloids (Blood Plasma) Product Portfolio Table 143. CR Double-Crane Recent Development Table 144. Kelun Group Company Information Table 145. Kelun Group Business Overview Table 146. Kelun Group Colloids (Blood Plasma) Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 147. Kelun Group Colloids (Blood Plasma) Product Portfolio Table 148. Kelun Group Recent Development Table 149. Shandong Qidu Pharmaceutical Company Information Table 150. Shandong Qidu Pharmaceutical Business Overview Table 151. Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 152. Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Product Portfolio Table 153. Shandong Qidu Pharmaceutical Recent Development Table 154. Shandong Hualu Pharmaceutical Company Information Table 155. Shandong Hualu Pharmaceutical Business Overview Table 156. Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 157. Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Product Portfolio Table 158. Shandong Hualu Pharmaceutical Recent Development Table 159. Minsheng Pharma Company Information Table 160. Minsheng Pharma Business Overview Table 161. Minsheng Pharma Colloids (Blood Plasma) Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 162. Minsheng Pharma Colloids (Blood Plasma) Product Portfolio Table 163. Minsheng Pharma Recent Development Table 164. Kanglepharm Company Information Table 165. Kanglepharm Business Overview Table 166. Kanglepharm Colloids (Blood Plasma) Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 167. Kanglepharm Colloids (Blood Plasma) Product Portfolio Table 168. Kanglepharm Recent Development Table 169. Key Raw Materials Table 170. Raw Materials Key Suppliers Table 171. Colloids (Blood Plasma) Distributors List Table 172. Colloids (Blood Plasma) Customers List Table 173. Research Programs/Design for This Report Table 174. Authors List of This Report Table 175. Secondary Sources Table 176. Primary Sources List of Figures Figure 1. Colloids (Blood Plasma) Product Image Figure 2. Global Colloids (Blood Plasma) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Colloids (Blood Plasma) Market Size (2021-2032) & (US$ Million) Figure 4. Global Colloids (Blood Plasma) Sales (2021-2032) & (MT) Figure 5. Global Colloids (Blood Plasma) Average Price (USD/Kg) & (2021-2032) Figure 6. Global Top 5 and 10 Colloids (Blood Plasma) Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Natural Type Colloids (Blood Plasma) Image Figure 9. Synthetic Type Colloids (Blood Plasma) Image Figure 10. Global Colloids (Blood Plasma) Sales by Type (2021 VS 2025 VS 2032) & (MT) Figure 11. Global Colloids (Blood Plasma) Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Colloids (Blood Plasma) Sales Market Share by Type (2021-2032) Figure 13. Global Colloids (Blood Plasma) Revenue by Type (2021 VS 2025 VS 2032) & (MT) Figure 14. Global Colloids (Blood Plasma) Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Colloids (Blood Plasma) Revenue Market Share by Type (2021-2032) Figure 16. Extensive Burns Image Figure 17. Massive Blood or Plasma Loss Image Figure 18. Hypovolemic Shock Image Figure 19. Others Image Figure 20. Global Colloids (Blood Plasma) Sales by Application (2021 VS 2025 VS 2032) & (MT) Figure 21. Global Colloids (Blood Plasma) Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Colloids (Blood Plasma) Sales Market Share by Application (2021-2032) Figure 23. Global Colloids (Blood Plasma) Revenue by Application (2021 VS 2025 VS 2032) & (MT) Figure 24. Global Colloids (Blood Plasma) Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Colloids (Blood Plasma) Revenue Market Share by Application (2021-2032) Figure 26. North America Colloids (Blood Plasma) Sales and Growth Rate (2021-2032) & (MT) Figure 27. North America Colloids (Blood Plasma) Sales Market Share by Country (2021-2032) Figure 28. U.S. Colloids (Blood Plasma) Sales and Growth Rate (2021-2032) & (MT) Figure 29. Canada Colloids (Blood Plasma) Sales and Growth Rate (2021-2032) & (MT) Figure 30. Mexico Colloids (Blood Plasma) Sales and Growth Rate (2021-2032) & (MT) Figure 31. Europe Colloids (Blood Plasma) Sales and Growth Rate (2021-2032) & (MT) Figure 32. Europe Colloids (Blood Plasma) Sales Market Share by Country (2021-2032) Figure 33. Germany Colloids (Blood Plasma) Sales and Growth Rate (2021-2032) & (MT) Figure 34. France Colloids (Blood Plasma) Sales and Growth Rate (2021-2032) & (MT) Figure 35. U.K. Colloids (Blood Plasma) Sales and Growth Rate (2021-2032) & (MT) Figure 36. Italy Colloids (Blood Plasma) Sales and Growth Rate (2021-2032) & (MT) Figure 37. Netherlands Colloids (Blood Plasma) Sales and Growth Rate (2021-2032) & (MT) Figure 38. Asia Pacific Colloids (Blood Plasma) Sales and Growth Rate (2021-2032) & (MT) Figure 39. Asia Pacific Colloids (Blood Plasma) Sales Market Share by Country (2021-2032) Figure 40. China Colloids (Blood Plasma) Sales and Growth Rate (2021-2032) & (MT) Figure 41. Japan Colloids (Blood Plasma) Sales and Growth Rate (2021-2032) & (MT) Figure 42. South Korea Colloids (Blood Plasma) Sales and Growth Rate (2021-2032) & (MT) Figure 43. Southeast Asia Colloids (Blood Plasma) Sales and Growth Rate (2021-2032) & (MT) Figure 44. India Colloids (Blood Plasma) Sales and Growth Rate (2021-2032) & (MT) Figure 45. Australia Colloids (Blood Plasma) Sales and Growth Rate (2021-2032) & (MT) Figure 46. South America, Middle East and Africa Colloids (Blood Plasma) Sales and Growth Rate (2021-2032) & (MT) Figure 47. South America, Middle East and Africa Colloids (Blood Plasma) Sales Market Share by Country (2021-2032) Figure 48. Brazil Colloids (Blood Plasma) Sales and Growth Rate (2021-2032) & (MT) Figure 49. South Africa Colloids (Blood Plasma) Sales and Growth Rate (2021-2032) & (MT) Figure 50. Saudi Arabia Colloids (Blood Plasma) Sales and Growth Rate (2021-2032) & (MT) Figure 51. Turkey Colloids (Blood Plasma) Sales and Growth Rate (2021-2032) & (MT) Figure 52. Argentina Colloids (Blood Plasma) Sales and Growth Rate (2021-2032) & (MT) Figure 53. UAE Colloids (Blood Plasma) Sales and Growth Rate (2021-2032) & (MT) Figure 54. Egypt Colloids (Blood Plasma) Sales and Growth Rate (2021-2032) & (MT) Figure 55. Chile Colloids (Blood Plasma) Sales and Growth Rate (2021-2032) & (MT) Figure 56. Global Colloids (Blood Plasma) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Colloids (Blood Plasma) Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Colloids (Blood Plasma) Revenue (2021-2032) & (US$ Million) Figure 59. North America Colloids (Blood Plasma) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Colloids (Blood Plasma) Revenue (2021-2032) & (US$ Million) Figure 61. Europe Colloids (Blood Plasma) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Colloids (Blood Plasma) Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Colloids (Blood Plasma) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Colloids (Blood Plasma) Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Colloids (Blood Plasma) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Colloids (Blood Plasma) Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Colloids (Blood Plasma) Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Natural Type Colloids (Blood Plasma)
  • Synthetic Type Colloids (Blood Plasma)
Applications
  • Extensive Burns
  • Massive Blood or Plasma Loss
  • Hypovolemic Shock
  • Others
Companies covered
  • CSL Behring
  • Baxter
  • Grifols
  • Octapharma
  • Kedrion
  • Shanghai Raas
  • CTBB
  • Hualan Bio
  • Rongsheng Pharmaceutical
  • Boya Rongsheng
  • B. Braun Medical
  • Fresenius Kabi
  • HOSPIRA
  • Axa parenterals
  • Fresenius Kabi (China)
  • CR Double-Crane
  • Kelun Group
  • Shandong Qidu Pharmaceutical
  • Shandong Hualu Pharmaceutical
  • Minsheng Pharma
  • Kanglepharm

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Colloids (Blood Plasma) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Colloids (Blood Plasma) Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Colloids (Blood Plasma) Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Colloids (Blood Plasma) Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Colloids (Blood Plasma) Market Dynamics
  1. 2.1 Colloids (Blood Plasma) Industry Trends
  2. 2.2 Colloids (Blood Plasma) Industry Drivers
  3. 2.3 Colloids (Blood Plasma) Industry Opportunities and Challenges
  4. 2.4 Colloids (Blood Plasma) Industry Restraints
3 Colloids (Blood Plasma) Market by Manufacturers
  1. 3.1 Global Colloids (Blood Plasma) Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Colloids (Blood Plasma) Sales by Manufacturers (2021-2026)
  3. 3.3 Global Colloids (Blood Plasma) Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Colloids (Blood Plasma) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Colloids (Blood Plasma) Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Colloids (Blood Plasma) Manufacturers, Product Type & Application
  7. 3.7 Global Colloids (Blood Plasma) Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Colloids (Blood Plasma) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Colloids (Blood Plasma) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Colloids (Blood Plasma) Tier 1, Tier 2, and Tier 3
4 Colloids (Blood Plasma) Market by Type
  1. 4.1 Colloids (Blood Plasma) Type Introduction
  2. 4.1.1 Natural Type Colloids (Blood Plasma)
  3. 4.1.2 Synthetic Type Colloids (Blood Plasma)
  4. 4.2 Global Colloids (Blood Plasma) Sales by Type
  5. 4.2.1 Global Colloids (Blood Plasma) Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Colloids (Blood Plasma) Sales by Type (2021-2032)
  7. 4.2.3 Global Colloids (Blood Plasma) Sales Market Share by Type (2021-2032)
  8. 4.3 Global Colloids (Blood Plasma) Revenue by Type
  9. 4.3.1 Global Colloids (Blood Plasma) Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Colloids (Blood Plasma) Revenue by Type (2021-2032)
  11. 4.3.3 Global Colloids (Blood Plasma) Revenue Market Share by Type (2021-2032)
5 Colloids (Blood Plasma) Market by Application
  1. 5.1 Colloids (Blood Plasma) Application Introduction
  2. 5.1.1 Extensive Burns
  3. 5.1.2 Massive Blood or Plasma Loss
  4. 5.1.3 Hypovolemic Shock
  5. 5.1.4 Others
  6. 5.2 Global Colloids (Blood Plasma) Sales by Application
  7. 5.2.1 Global Colloids (Blood Plasma) Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Colloids (Blood Plasma) Sales by Application (2021-2032)
  9. 5.2.3 Global Colloids (Blood Plasma) Sales Market Share by Application (2021-2032)
  10. 5.3 Global Colloids (Blood Plasma) Revenue by Application
  11. 5.3.1 Global Colloids (Blood Plasma) Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Colloids (Blood Plasma) Revenue by Application (2021-2032)
  13. 5.3.3 Global Colloids (Blood Plasma) Revenue Market Share by Application (2021-2032)
6 Global Colloids (Blood Plasma) Sales by Region
  1. 6.1 Global Colloids (Blood Plasma) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Colloids (Blood Plasma) Sales by Region (2021-2032)
  3. 6.2.1 Global Colloids (Blood Plasma) Sales by Region (2021-2026)
  4. 6.2.2 Global Colloids (Blood Plasma) Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Colloids (Blood Plasma) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Colloids (Blood Plasma) Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Colloids (Blood Plasma) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Colloids (Blood Plasma) Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Colloids (Blood Plasma) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Colloids (Blood Plasma) Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Colloids (Blood Plasma) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Colloids (Blood Plasma) Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Colloids (Blood Plasma) Revenue by Region
  1. 7.1 Global Colloids (Blood Plasma) Revenue by Region
  2. 7.1.1 Global Colloids (Blood Plasma) Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Colloids (Blood Plasma) Revenue by Region (2021-2026)
  4. 7.1.3 Global Colloids (Blood Plasma) Revenue by Region (2027-2032)
  5. 7.1.4 Global Colloids (Blood Plasma) Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Colloids (Blood Plasma) Revenue (2021-2032)
  8. 7.2.2 North America Colloids (Blood Plasma) Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Colloids (Blood Plasma) Revenue (2021-2032)
  11. 7.3.2 Europe Colloids (Blood Plasma) Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Colloids (Blood Plasma) Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Colloids (Blood Plasma) Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Colloids (Blood Plasma) Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Colloids (Blood Plasma) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 CSL Behring
  2. 8.1.1 CSL Behring Company Information
  3. 8.1.2 CSL Behring Business Overview
  4. 8.1.3 CSL Behring Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 CSL Behring Colloids (Blood Plasma) Product Portfolio
  6. 8.1.5 CSL Behring Recent Developments
  7. 8.2 Baxter
  8. 8.2.1 Baxter Company Information
  9. 8.2.2 Baxter Business Overview
  10. 8.2.3 Baxter Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Baxter Colloids (Blood Plasma) Product Portfolio
  12. 8.2.5 Baxter Recent Developments
  13. 8.3 Grifols
  14. 8.3.1 Grifols Company Information
  15. 8.3.2 Grifols Business Overview
  16. 8.3.3 Grifols Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Grifols Colloids (Blood Plasma) Product Portfolio
  18. 8.3.5 Grifols Recent Developments
  19. 8.4 Octapharma
  20. 8.4.1 Octapharma Company Information
  21. 8.4.2 Octapharma Business Overview
  22. 8.4.3 Octapharma Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Octapharma Colloids (Blood Plasma) Product Portfolio
  24. 8.4.5 Octapharma Recent Developments
  25. 8.5 Kedrion
  26. 8.5.1 Kedrion Company Information
  27. 8.5.2 Kedrion Business Overview
  28. 8.5.3 Kedrion Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Kedrion Colloids (Blood Plasma) Product Portfolio
  30. 8.5.5 Kedrion Recent Developments
  31. 8.6 Shanghai Raas
  32. 8.6.1 Shanghai Raas Company Information
  33. 8.6.2 Shanghai Raas Business Overview
  34. 8.6.3 Shanghai Raas Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Shanghai Raas Colloids (Blood Plasma) Product Portfolio
  36. 8.6.5 Shanghai Raas Recent Developments
  37. 8.7 CTBB
  38. 8.7.1 CTBB Company Information
  39. 8.7.2 CTBB Business Overview
  40. 8.7.3 CTBB Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 CTBB Colloids (Blood Plasma) Product Portfolio
  42. 8.7.5 CTBB Recent Developments
  43. 8.8 Hualan Bio
  44. 8.8.1 Hualan Bio Company Information
  45. 8.8.2 Hualan Bio Business Overview
  46. 8.8.3 Hualan Bio Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Hualan Bio Colloids (Blood Plasma) Product Portfolio
  48. 8.8.5 Hualan Bio Recent Developments
  49. 8.9 Rongsheng Pharmaceutical
  50. 8.9.1 Rongsheng Pharmaceutical Company Information
  51. 8.9.2 Rongsheng Pharmaceutical Business Overview
  52. 8.9.3 Rongsheng Pharmaceutical Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Rongsheng Pharmaceutical Colloids (Blood Plasma) Product Portfolio
  54. 8.9.5 Rongsheng Pharmaceutical Recent Developments
  55. 8.10 Boya Rongsheng
  56. 8.10.1 Boya Rongsheng Company Information
  57. 8.10.2 Boya Rongsheng Business Overview
  58. 8.10.3 Boya Rongsheng Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Boya Rongsheng Colloids (Blood Plasma) Product Portfolio
  60. 8.10.5 Boya Rongsheng Recent Developments
  61. 8.11 B. Braun Medical
  62. 8.11.1 B. Braun Medical Company Information
  63. 8.11.2 B. Braun Medical Business Overview
  64. 8.11.3 B. Braun Medical Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 B. Braun Medical Colloids (Blood Plasma) Product Portfolio
  66. 8.11.5 B. Braun Medical Recent Developments
  67. 8.12 Fresenius Kabi
  68. 8.12.1 Fresenius Kabi Company Information
  69. 8.12.2 Fresenius Kabi Business Overview
  70. 8.12.3 Fresenius Kabi Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Fresenius Kabi Colloids (Blood Plasma) Product Portfolio
  72. 8.12.5 Fresenius Kabi Recent Developments
  73. 8.13 HOSPIRA
  74. 8.13.1 HOSPIRA Company Information
  75. 8.13.2 HOSPIRA Business Overview
  76. 8.13.3 HOSPIRA Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 HOSPIRA Colloids (Blood Plasma) Product Portfolio
  78. 8.13.5 HOSPIRA Recent Developments
  79. 8.14 Axa parenterals
  80. 8.14.1 Axa parenterals Company Information
  81. 8.14.2 Axa parenterals Business Overview
  82. 8.14.3 Axa parenterals Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Axa parenterals Colloids (Blood Plasma) Product Portfolio
  84. 8.14.5 Axa parenterals Recent Developments
  85. 8.15 Fresenius Kabi (China)
  86. 8.15.1 Fresenius Kabi (China) Company Information
  87. 8.15.2 Fresenius Kabi (China) Business Overview
  88. 8.15.3 Fresenius Kabi (China) Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Fresenius Kabi (China) Colloids (Blood Plasma) Product Portfolio
  90. 8.15.5 Fresenius Kabi (China) Recent Developments
  91. 8.16 CR Double-Crane
  92. 8.16.1 CR Double-Crane Company Information
  93. 8.16.2 CR Double-Crane Business Overview
  94. 8.16.3 CR Double-Crane Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 CR Double-Crane Colloids (Blood Plasma) Product Portfolio
  96. 8.16.5 CR Double-Crane Recent Developments
  97. 8.17 Kelun Group
  98. 8.17.1 Kelun Group Company Information
  99. 8.17.2 Kelun Group Business Overview
  100. 8.17.3 Kelun Group Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Kelun Group Colloids (Blood Plasma) Product Portfolio
  102. 8.17.5 Kelun Group Recent Developments
  103. 8.18 Shandong Qidu Pharmaceutical
  104. 8.18.1 Shandong Qidu Pharmaceutical Company Information
  105. 8.18.2 Shandong Qidu Pharmaceutical Business Overview
  106. 8.18.3 Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Product Portfolio
  108. 8.18.5 Shandong Qidu Pharmaceutical Recent Developments
  109. 8.19 Shandong Hualu Pharmaceutical
  110. 8.19.1 Shandong Hualu Pharmaceutical Company Information
  111. 8.19.2 Shandong Hualu Pharmaceutical Business Overview
  112. 8.19.3 Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Product Portfolio
  114. 8.19.5 Shandong Hualu Pharmaceutical Recent Developments
  115. 8.20 Minsheng Pharma
  116. 8.20.1 Minsheng Pharma Company Information
  117. 8.20.2 Minsheng Pharma Business Overview
  118. 8.20.3 Minsheng Pharma Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Minsheng Pharma Colloids (Blood Plasma) Product Portfolio
  120. 8.20.5 Minsheng Pharma Recent Developments
  121. 8.21 Kanglepharm
  122. 8.21.1 Kanglepharm Company Information
  123. 8.21.2 Kanglepharm Business Overview
  124. 8.21.3 Kanglepharm Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Kanglepharm Colloids (Blood Plasma) Product Portfolio
  126. 8.21.5 Kanglepharm Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Colloids (Blood Plasma) Value Chain Analysis
  2. 9.1.1 Colloids (Blood Plasma) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Colloids (Blood Plasma) Production Mode & Process
  6. 9.2 Colloids (Blood Plasma) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Colloids (Blood Plasma) Distributors
  9. 9.2.3 Colloids (Blood Plasma) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst